Mass. Sues J&J Unit Over Risperdal Off-Label Marketing

Law360, New York (August 1, 2011, 7:49 PM EDT) -- The Massachusetts attorney general hit a subsidiary of Johnson & Johnson with a lawsuit Monday, accusing the drug company of illegally marketing the antipsychotic drug Risperdal for off-label uses in children and the elderly.

According to the state, Ortho-McNeil-Janssen Pharmaceuticals Inc. aggressivley pushed the drug, known generically as risperidone, to physicians working with children and with elderly patients suffering from dementia even though the drug wasn't yet approved for such patients. Although it is legal for a doctor to prescribe a drug for an off-label use,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.